|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer. Apr 5–2021.(Epub ahead of
print). doi: 10.1002/ijc.33588. View Article : Google Scholar
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
3
|
European Association for the Study of the
Liver, . EASL Clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 69:182–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Y, Wang ZX, Cao Y, Zhang G, Chen WB
and Jiang CP: Preoperative inflammation-based markers predict early
and late recurrence of hepatocellular carcinoma after curative
hepatectomy. Hepatobiliary Pancreat Dis Int. 15:266–274. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng S, Chen M, Cai J, Sun J, Guo R, Bi
X, Lau WY and Wu M: Chinese expert consensus on multidisciplinary
diagnosis and treatment of hepatocellular carcinoma with portal
vein tumor thrombus (2018 Edition). Liver Cancer. 9:28–40. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khan AR, Wei X and Xu X: Portal vein tumor
thrombosis and hepatocellular carcinoma-the changing tides. J
Hepatocell Carcinoma. 8:1089–115. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo F, Li M, Ding J and Zheng S: The
progress in the treatment of hepatocellular carcinoma with portal
vein tumor thrombus. Front Oncol. 11:6357312021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schöniger-Hekele M, Müller C, Kutilek M,
Oesterreicher C, Ferenci P and Gangl A: Hepatocellular carcinoma in
Central Europe: Prognostic features and survival. Gut. 48:103–109.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giannini EG, Bucci L, Garuti F, Brunacci
M, Lenzi B, Valente M, Caturelli E, Cabibbo G, Piscaglia F, Virdone
R, et al: Patients with advanced hepatocellular carcinoma need a
personalized management: A lesson from clinical practice.
Hepatology. 67:1784–1796. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun J, Guo R, Bi X, Wu M, Tang Z, Lau WY,
Zheng S, Wang X, Yu J, Chen X, et al: Guidelines for diagnosis and
treatment of hepatocellular carcinoma with portal vein tumor
thrombus in China (2021 Edition). Liver Cancer. 11:315–328. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bai S, Wu Y, Yan Y, Li R, Kang H, Zhang J,
Ma W, Gao Y, Hui B, Ma H, et al: Evaluation of the efficacy and
toxicity of radiotherapy for Type III–IV portal vein tumor thrombi.
Technol Cancer Res Treat. 20:15330338219952862021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Finn RS, Zhu AX, Farah W, Almasri J, Zaiem
F, Prokop LJ, Murad MH and Mohammed K: Therapies for advanced stage
hepatocellular carcinoma with macrovascular invasion or metastatic
disease: A systematic review and meta-analysis. Hepatology.
67:422–435. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
China DoMAotNHCotPsRo: Guideline for
diagnosis and treatment of primary liver cancer (2024 edition).
Chin J Magn Reson Imaging. 15:1–18. 2024.
|
|
15
|
Bi X, Zhao H, Zhao H, Li G, Wang X, Chen
B, Zhang W, Che X, Huang Z, Han Y, et al: Consensus of Chinese
experts on neoadjuvant and conversion therapies for hepatocellular
carcinoma: 2023 update. Liver Cancer. 14:223–238. 2024.PubMed/NCBI
|
|
16
|
Mendiratta-Lala M, Batra S, Lala K, Kohn M
and Owen D: Multidisciplinary assessment of tumor response after
internal and external radiation therapy for hepatocellular
carcinoma. Hepatoma Res. 10:312024.
|
|
17
|
Apisarnthanarax S, Barry A, Cao M, Czito
B, DeMatteo R, Drinane M, Hallemeier CL, Koay EJ, Lasley F, Meyer
J, et al: External beam radiation therapy for primary liver
cancers: An ASTRO clinical practice guideline. Pract Radiat Oncol.
12:28–51. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen CP: Role of external beam
radiotherapy in hepatocellular carcinoma. Clin Liver Dis.
24:701–717. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Klein J and Dawson LA: Hepatocellular
carcinoma radiation therapy: Review of evidence and future
opportunities. Int J Radiat Oncol Biol Phys. 87:22–32. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SH, Kim JC and Kang MK: Technical
advances in external radiotherapy for hepatocellular carcinoma.
World J Gastroenterol. 22:7311–7321. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei Z, Zhao J, Bi X, Zhang Y, Zhou J, Li
Z, Huang Z, Zhao H and Cai J: Neoadjuvant radiotherapy for
resectable hepatocellular carcinoma with portal vein tumor
thrombus: A systematic review. Hepatobiliary Surg Nutr. 11:709–717.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamiyama T, Nakanishi K, Yokoo H, Tahara
M, Nakagawa T, Kamachi H, Taguchi H, Shirato H, Matsushita M and
Todo S: Efficacy of preoperative radiotherapy to portal vein tumor
thrombus in the main trunk or first branch in patients with
hepatocellular carcinoma. Int J Clin Oncol. 12:363–368. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li N, Feng S, Xue J, Wei XB, Shi J, Guo
WX, Lau WY, Wu MC, Cheng SQ and Meng Y: Hepatocellular carcinoma
with main portal vein tumor thrombus: A comparative study comparing
hepatectomy with or without neoadjuvant radiotherapy. HPB (Oxford).
18:549–556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei X, Jiang Y, Zhang X, Feng S, Zhou B,
Ye X, Xing H, Xu Y, Shi J, Guo W, et al: Neoadjuvant
Three-dimensional conformal radiotherapy for resectable
hepatocellular carcinoma with portal vein tumor thrombus: A
randomized, Open-label, multicenter controlled study. J Clin Oncol.
37:2141–2151. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei X, Jiang Y, Feng S, Lu C, Huo L, Zhou
B, Meng Y, Lau WY, Zheng Y and Cheng S: Neoadjuvant intensity
modulated radiotherapy for a single and small (≤5 cm) hepatitis B
virus-related hepatocellular carcinoma predicted to have high risks
of microvascular invasion: A randomized clinical trial. Int J Surg.
109:3052–3060. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Costentin CE, Ferrone CR, Arellano RS,
Ganguli S, Hong TS and Zhu AX: Hepatocellular carcinoma with
macrovascular invasion: Defining the optimal treatment strategy.
Liver Cancer. 6:360–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bruix J, Raoul JL, Sherman M, Mazzaferro
V, Bolondi L, Craxi A, Galle PR, Santoro A, Beaugrand M,
Sangiovanni A, et al: Efficacy and safety of sorafenib in patients
with advanced hepatocellular carcinoma: Subanalyses of a phase III
trial. J Hepatol. 57:821–829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kishi N, Kanayama N, Hirata T, Ohira S,
Wada K, Kawaguchi Y, Konishi K, Nagata S, Nakatsuka SI, Marubashi
S, et al: Preoperative stereotactic body radiotherapy to portal
vein tumour thrombus in hepatocellular carcinoma: Clinical and
pathological analysis. Sci Rep. 10:41052020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen B, Li Y, Wang L, Wu J, Zhai YR, Wu F,
Zeng H, Rong W, Wang SL, Wang J, et al: Phase II study of
concurrent sorafenib and radiotherapy for advanced hepatocellular
carcinoma with portal Vein and/or Hepatic vein tumor thrombosis.
Int J Radiation Oncol Biol Physics. 111 (Suppl):S392021. View Article : Google Scholar
|
|
31
|
Shi C, Li Y, Geng L, Shen W, Sui C, Dai B,
Lu J, Pan M and Yang J: Adjuvant stereotactic body radiotherapy
after marginal resection for hepatocellular carcinoma with
microvascular invasion: A randomised controlled trial. Eur J
Cancer. 166:176–184. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Wang W, Yao X, Rong W, Wu F, Chen
B, Liu M, Lin S, Liu Y, Wu J, et al: Postoperative adjuvant
radiotherapy is associated with improved survival in hepatocellular
carcinoma with microvascular invasion. Oncotarget. 8:79971–79981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng JC, Chou CH, Kuo ML and Hsieh CY:
Radiation-enhanced hepatocellular carcinoma cell invasion with
MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction
pathway. Oncogene. 25:7009–7018. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pan Y, Zhou C, Yuan D, Zhang J and Shao C:
Radiation exposure promotes hepatocarcinoma cell invasion through
epithelial mesenchymal transition mediated by H2S/CSE pathway.
Radiat Res. 185:96–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sanford NN, Pursley J, Noe B, Yeap BY,
Goyal L, Clark JW, Allen JN, Blaszkowsky LS, Ryan DP, Ferrone CR,
et al: Protons versus photons for unresectable hepatocellular
carcinoma: Liver decompensation and overall survival. Int J Radiat
Oncol Biol Phys. 105:64–72. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoo GS, Yu JI, Park HC, Hyun D, Jeong WK,
Lim HY, Choi MS and Ha SY: Do biliary complications after proton
beam therapy for perihilar hepatocellular carcinoma matter? Cancers
(Basel). 12:23952020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
European Association for the Study of the
Liver, . EASL Clinical Practice Guidelines on the management of
hepatocellular carcinoma. J Hepatol. 82:315–374. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yeh SA, Chen YS and Perng DS: The role of
radiotherapy in the treatment of hepatocellular carcinoma with
portal vein tumor thrombus. J Radiat Res. 56:325–331. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cho Y, Kim BH and Park JW: Overview of
Asian clinical practice guidelines for the management of
hepatocellular carcinoma: An Asian perspective comparison. Clin Mol
Hepatol. 29:252–262. 2023. View Article : Google Scholar : PubMed/NCBI
|
